Association of Anthropometric Characteristics with the Risk of Malignant Lymphoma and Plasma Cell Myeloma in a Japanese Population: A Population-Based Cohort Study

  • Junya Kanda
    Authors' Affiliations: 1Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute; 2Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 3Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan; and 4Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • Keitaro Matsuo
    Authors' Affiliations: 1Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute; 2Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 3Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan; and 4Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • Manami Inoue
    Authors' Affiliations: 1Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute; 2Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 3Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan; and 4Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • Motoki Iwasaki
    Authors' Affiliations: 1Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute; 2Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 3Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan; and 4Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • Norie Sawada
    Authors' Affiliations: 1Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute; 2Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 3Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan; and 4Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • Taichi Shimazu
    Authors' Affiliations: 1Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute; 2Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 3Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan; and 4Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • Taiki Yamaji
    Authors' Affiliations: 1Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute; 2Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 3Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan; and 4Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • Shizuka Sasazuki
    Authors' Affiliations: 1Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute; 2Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 3Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan; and 4Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • Shoichiro Tsugane
    Authors' Affiliations: 1Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute; 2Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 3Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan; and 4Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

抄録

<jats:title>Abstract</jats:title><jats:p>Background: Although Asian and Western populations differ markedly in anthropometric characteristics and the incidence of malignant lymphoma and plasma cell myeloma, few studies have evaluated the associations between these variables among Asian populations.</jats:p><jats:p>Methods: We conducted a large-scale, population-based prospective study in a Japanese cohort that included 45,007 men and 49,540 women ages 40 to 69 years at baseline. During an average follow-up period of 13 years, 257 cases of malignant lymphoma and 88 of plasma cell myeloma were identified. Hazard ratios (HR) and 95% confidence intervals (95% CI) were estimated with the use of a Cox regression model adjusted for potential confounders.</jats:p><jats:p>Results: Compared with the 1st quartile, categorization in the 4th quartile for height showed a positive association with lymphoid neoplasm risk (HR, 1.38; 95% CI, 1.00-1.91), and the association was significant among men (HR, 1.72; 95% CI, 1.11-2.66). A similar trend was observed for subcategories of malignant lymphoma, plasma cell myeloma, and non–Hodgkin lymphoma, albeit the associations were weak due to the small number of subjects in each category. In contrast, weight and body mass index were not associated with risk of lymphoid neoplasm.</jats:p><jats:p>Conclusions: Height was positively associated with risk of lymphoid neoplasm in a Japanese population.</jats:p><jats:p>Impact: Our data suggested that early life exposure to growth-related hormones, such as insulin-like growth factors and growth hormones, or genetic factors relating to height may affect the risk of lymphoid neoplasm. Cancer Epidemiol Biomarkers Prev; 19(6); 1623–31. ©2010 AACR.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ